Insider · CIK 0001325697

ANDREWS DEBORAH J

Reports to the SEC for 2 companies · LAKE FOREST, CA

sec.gov

Transactions

Companies

Filings

CIK

0001325697

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-14	STAASTAAR SURGICAL CO · Restricted Stock UnitsA Award	Chief Financial Officer & EVP	AAward	+4,975 sh	—	—	4,975
2026-08-14	STAASTAAR SURGICAL CO · Performance Stock Option (right to buy)A Award	Chief Financial Officer & EVP	AAward	+29.2K sh	—	—	29,159
2026-08-14	STAASTAAR SURGICAL CO · Stock Option (right to buy)A Award	Chief Financial Officer & EVP	AAward	+8,952 sh	—	—	8,952
2026-08-14	STAASTAAR SURGICAL CO · Performance Stock UnitsM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	+5,233 sh	—	—	41,452
2026-08-14	STAASTAAR SURGICAL COF Tax Payment	Chief Financial Officer & EVP	FTax Payment	−2,662 sh	$26.18	−$69.7K	38,910
2026-08-14	STAASTAAR SURGICAL COM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	+5,233 sh	—	—	41,452
2026-07-31	STAASTAAR SURGICAL COM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	+20.8K sh	—	—	46,915
2026-07-31	STAASTAAR SURGICAL CO · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	−20.8K sh	—	—	0
2026-07-31	STAASTAAR SURGICAL COF Tax Payment	Chief Financial Officer & EVP	FTax Payment	−10.6K sh	$24.36	−$258K	36,339
2026-07-01	LCTXLineage Cell Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+125K sh	—	—	125,000
2026-06-25	STAASTAAR SURGICAL COF Tax Payment	Chief Financial Officer & EVP	FTax Payment	−6,480 sh	$31.21	−$202K	26,128
2026-06-25	STAASTAAR SURGICAL CO · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	−14K sh	—	—	27,912
2026-06-25	STAASTAAR SURGICAL COM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	+14K sh	—	—	32,608
2026-05-15	STAASTAAR SURGICAL CO · Performance Stock UnitsM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	+5,233 sh	—	—	15,699
2026-05-15	STAASTAAR SURGICAL CO · Performance Stock UnitsM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	+10.5K sh	—	—	10,466
2026-05-15	STAASTAAR SURGICAL COF Tax Payment	Chief Financial Officer & EVP	FTax Payment	−3,755 sh	$32.07	−$120K	15,297
2026-05-15	STAASTAAR SURGICAL COA Award	Chief Financial Officer & EVP	AAward	+5,233 sh	—	—	20,530
2026-05-15	STAASTAAR SURGICAL COA Award	Chief Financial Officer & EVP	AAward	+10.5K sh	—	—	10,466
2026-05-15	STAASTAAR SURGICAL COF Tax Payment	Chief Financial Officer & EVP	FTax Payment	−1,877 sh	$32.07	−$60.2K	18,653
2026-03-13	STAASTAAR SURGICAL CO · Restricted Stock UnitsA Award	Chief Financial Officer & EVP	AAward	+39.8K sh	—	—	39,809
2026-02-02	STAASTAAR SURGICAL CO · Restricted Stock UnitsA Award	Chief Financial Officer & EVP	AAward	+20.8K sh	—	—	20,787
2025-07-01	LCTXLineage Cell Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2025-06-25	STAASTAAR SURGICAL CO · Restricted Stock UnitsA Award	Chief Financial Officer & EVP	AAward	+41.9K sh	—	—	41,867
2024-07-01	LCTXLineage Cell Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2023-07-01	LCTXLineage Cell Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2022-07-01	LCTXLineage Cell Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2021-07-01	LCTXLineage Cell Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2021-06-29	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+24.7K sh	$2.20	+$54.4K	34,720
2021-06-29	LCTXLineage Cell Therapeutics, Inc.S Sale	Director	SSale	−19.1K sh	$2.93	−$56.1K	15,578
2021-06-29	LCTXLineage Cell Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−24.7K sh	—	—	0
2020-07-01	LCTXLineage Cell Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-03-23	STAASTAAR SURGICAL COS Sale	Chief Financial Officer & EVP	SSale	−834 sh	$27.42	−$22.9K	31,267
2020-01-21	STAASTAAR SURGICAL COM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	+17.4K sh	$15.25	+$265K	128,044
2020-01-21	STAASTAAR SURGICAL COM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	+4,583 sh	$9.30	+$42.6K	110,684
2020-01-21	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	−3,370 sh	—	—	188
2020-01-21	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	−7,291 sh	—	—	347
2020-01-21	STAASTAAR SURGICAL COM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	+9,000 sh	$7.36	+$66.2K	106,101
2020-01-21	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	−17.4K sh	—	—	695
2020-01-21	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	−4,583 sh	—	—	139
2020-01-21	STAASTAAR SURGICAL COM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	+15K sh	$7.35	+$110K	97,101
2020-01-21	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	−9,000 sh	—	—	0
2020-01-21	STAASTAAR SURGICAL COM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	+10K sh	$15.54	+$155K	82,101
2020-01-21	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	−15K sh	—	—	0
2020-01-21	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	−10K sh	—	—	0
2020-01-21	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	−20K sh	—	—	0
2020-01-21	STAASTAAR SURGICAL COM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	+20K sh	$5.34	+$107K	72,101
2020-01-21	STAASTAAR SURGICAL CO · Common Stock OptionsM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	−20K sh	—	—	0
2020-01-21	STAASTAAR SURGICAL COS Sale	Chief Financial Officer & EVP	SSale	−107K sh	$42.20	−$4.5M	32,101
2020-01-21	STAASTAAR SURGICAL COM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	+3,370 sh	$29.80	+$100K	138,705
2020-01-21	STAASTAAR SURGICAL COM Exercise/Conversion	Chief Financial Officer & EVP	MExercise/Conversion	+7,291 sh	$16.15	+$118K	135,335

Recent filings

Accepted (ET)
Aug 184
ANDREWS DEBORAH J0001325697-26-000011
SEC(opens sec.gov)
Aug 44
ANDREWS DEBORAH J0001325697-26-000009
SEC(opens sec.gov)
Jul 24
ANDREWS DEBORAH J0001193125-26-294860
SEC(opens sec.gov)
May 194
ANDREWS DEBORAH J0001325697-26-000006
SEC(opens sec.gov)
Mar 164
ANDREWS DEBORAH J0001325697-26-000002
SEC(opens sec.gov)

Companies

Address

25510 COMMERCENTRE DRIVE

LAKE FOREST, CA, 92630